Agencies · awarding agency 075 · HHS
Department of Health and Human Services
Share of this agency’s prime contract dollars that it coded “not competed”, by fiscal year, from USAspending’s agency totals.
Contract dollars by fiscal year
All prime contract obligations of the agency, split by the agency's competition code. Every figure is from USAspending's agency totals.
| Fiscal year | All contract obligations | Not competed | Competed | Share not competed |
|---|---|---|---|---|
| FY2024Oct 1 – Sep 30, 2024 | $29.9B | $2.8B | $27.1B | 9.2% |
| FY2025Oct 1 – Sep 30, 2025 | $21.3B | $2.5B | $18.8B | 11.5% |
| FY2026Oct 1 – Sep 30, 2026 | $24.9B | $2.9B | $22.0B | 11.6% |
Source: USAspending.gov agency totals, prime contract types A–D, by contract-action date; fetched Oct 3, 2026. “Not competed” = extent-competed code not available for competition, not competed, not competed under simplified acquisition, or non-competitive delivery order. Orders placed under a competed contract keep its code, so they count as competed.
Largest non-competed awards in our records
A look at the biggest individual awards behind the share. These rows do not add up to the totals above.
| Source | |||||
|---|---|---|---|---|---|
| 7571MN26C00029LEGAL SERVICES BRIDGE 2.0 | OUR RESCUE | Aug 7, 2026FY2026 | Not competedUrgency (FAR 6.302-2) | $158,124,790 | USAspending |
| 75A50124C00057ERVEBO PROCUREMENT | MERCK SHARP & DOHME LLC | Sep 27, 2024FY2024 | Not competedOnly one source-other (FAR 6.302-1 other) | $156,033,983 | USAspending |
| 75A50324C00006ANTHIM (OBILTOXAXIMAB) | ELUSYS THERAPEUTICS INC | Apr 30, 2024FY2024 | Not competedMobilization, essential r&d (FAR 6.302-3) | $124,523,123 | USAspending |
| 75N99024F00038Order under IDV 47PA0420D0064C107469 ELECTRICAL SUBSTATION UPGRADE PHASE 1A | POTOMAC ELECTRIC POWER CO | Sep 26, 2024FY2024 | Not available for competitionUtilities (FAR 6.302-1(b)(3)) | $122,189,393 | USAspending |
| 75N90025C00008PHARMACEUTICALS AND RELATED SUPPLIES FOR NIH CLINICAL CENTER, PHARMACY DEPT. UNITED STATES DEPARTMENT OF DEFENSE:1133869 [25-001813] | DLA TROOP SUPPORT | Feb 6, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $93,536,123 | USAspending |
| 75N90024C00007PHARMACEUTICALS AND RELATED SUPPLIES FOR THE NIH CLINICAL CENTER (CC), PHARMACY DEPARTMENT. | DLA TROOP SUPPORT | Nov 14, 2023FY2024 | Not competedOnly one source-other (FAR 6.302-1 other) | $82,620,000 | USAspending |
| 75N98026C00026PHARMACEUTICALS AND RELATED SUPPLIES UNITED STATES DEPARTMENT OF DEFENSE:1133869 [26-003472] | DLA TROOP SUPPORT | Apr 9, 2026FY2026 | Not competedOnly one source-other (FAR 6.302-1 other) | $77,389,000 | USAspending |
| 75D30124C19450DOSE RECONSTRUCTION | OAK RIDGE ASSOCIATED UNIVERSITIES, INCORPORATED | Aug 9, 2024FY2024 | Not competedOnly one source-other (FAR 6.302-1 other) | $57,750,000 | USAspending |
| 75A50125C00002MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE | SANOFI VACCINES US INC. | Jan 31, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $53,212,199 | USAspending |
| 75D30125C20468ATL FT COLLINS GUARDS BRIDGE | CHENEGA GLOBAL PROTECTION, LLC | Sep 4, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $49,658,504 | USAspending |
| 75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MG | GLAXOSMITHKLINE, LLC | Sep 26, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $45,499,950 | USAspending |
| 75FCMC24F0196Order under IDV 75FCMC23D0004POLICY AND OPERATIONAL SERVICES IN SUPPORT OF THE CONSUMER SUPPORT GROUP (CSG) FOR THE CENTER FOR CONSUMER INFORMATION AND INSURANCE OVERSIGHT (CCIIO) | THE MITRE CORPORATION | Sep 23, 2024FY2024 | Not competedMobilization, essential r&d (FAR 6.302-3) | $45,440,097 | USAspending |
| 75D30126C21564EO 14398 - CDC EMERGENCY MASS NOTIFICATION SYSTEM (EMNS) | CHENEGA ENTERPRISE SYSTEMS & SOLUTIONS, LLC | Sep 28, 2026FY2026 | Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i)) | $37,385,495 | USAspending |
| 75R60225C00001PRB184 C 5299 COVID-19 UNINSURED AND PROVIDER RELIEF FUND CLOSE-OUT SERVICES | OPTUMSERVE TECHNOLOGY SERVICES, INC. | Oct 11, 2024FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $35,520,831 | USAspending |
| 75FCMC24F0200Order under IDV 75FCMC23D0004STRATEGIC SERVICES IN SUPPORT OF FACILITATING LEADERSHIP IN ADVANCED MEASUREMENT EXCELLENCE (FLAME) | THE MITRE CORPORATION | Sep 16, 2024FY2024 | Not competedMobilization, essential r&d (FAR 6.302-3) | $35,210,195 | USAspending |
| 75ACF124C00023CASE COORDINATION BRIDGE | GENERAL DYNAMICS INFORMATION TECHNOLOGY, INC. | Sep 30, 2024FY2024 | Not competedOnly one source-other (FAR 6.302-1 other) | $35,175,033 | USAspending |
| 75FCMC24F0100Order under IDV 75FCMC23D0004TITLE IS SOLUTIONS TO SUPPORT INNOVATION IN PURSUIT OF AFFORDABLE AND BETTER HEALTH CARE | THE MITRE CORPORATION | Jun 26, 2024FY2024 | Not competedMobilization, essential r&d (FAR 6.302-3) | $33,645,144 | USAspending |
| 75A50325C00020RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG) | RAFA LABORATORIES LTD | Sep 30, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $33,392,937 | USAspending |
| 75F40126C00029SENTINEL 2.0 BRIDGE CONTRACT | HARVARD PILGRIM HEALTH CARE, INC. | Mar 26, 2026FY2026 | Not competedOnly one source-other (FAR 6.302-1 other) | $32,918,651 | USAspending |
| 75FCMC25FJ092Order under IDV 75FCMC23D0004THE PURPOSE OF THIS REWARD IS TO REPLACE THE ORIGINAL ADVANCING THE MEDICAID IT AMIT AWARD 75FCMC18D0047/ 75FCMC25FJ068 DUE TO AN ADMINISTRATIVE ERROR WHICH OCCURRED AT THE TIME OF AWARD. NONE OF THE TERMS AND CONDITIONS HAVE CHANGES AND ALL ATTACHME | THE MITRE CORPORATION | Jul 30, 2025FY2025 | Not competedMobilization, essential r&d (FAR 6.302-3) | $26,686,962 | USAspending |
| 75A50424C00006OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION | ATLANTIC TRADING LLC | Sep 5, 2024FY2024 | Not competedMobilization, essential r&d (FAR 6.302-3) | $26,510,400 | USAspending |
| 75D30124C19403NATIONAL PROGRAM OF CANCER REGISTRIES CANCER SURVEILLANCE INFORMATICS SYSTEM | GC&E FEDERAL, LLC | Jul 17, 2024FY2024 | Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i)) | $26,321,728 | USAspending |
| 75P00125C00034HHS PROCESSES IMPROVEMENT & ATO TRANSFORMATION | SKYLIGHT INC. | Sep 30, 2025FY2025 | Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i)) | $25,242,264 | USAspending |
| 75D30126C20921DOSE RECONSTRUCTION AND RELATED ACTIVITIES TO SUPPORT NIOSH'S RESPONSIBILITIES UNDER THE EEOICPA | OAK RIDGE ASSOCIATED UNIVERSITIES, INCORPORATED | Apr 17, 2026FY2026 | Not competedOnly one source-other (FAR 6.302-1 other) | $24,823,495 | USAspending |
| 75H70124C00052WESTERN OREGON SERVICE UNIT (WOSU) SCHOOL BASED HEALTH CENTER (SBHC) DESIGN-BUILD | TSS-JCC LLC | Sep 27, 2024FY2024 | Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i)) | $22,640,641 | USAspending |
Largest non-competed awards from Department of Health and Human Services, FY2024–26 (obligated to date)
- 7571MN26C00029LEGAL SERVICES BRIDGE 2.0
- Signed
- Aug 7, 2026FY2026
- Competition
- Not competedUrgency (FAR 6.302-2)
- Obligated to date
- $158,124,790
- 75A50124C00057ERVEBO PROCUREMENT
- Signed
- Sep 27, 2024FY2024
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $156,033,983
- 75A50324C00006ANTHIM (OBILTOXAXIMAB)
- Signed
- Apr 30, 2024FY2024
- Competition
- Not competedMobilization, essential r&d (FAR 6.302-3)
- Obligated to date
- $124,523,123
- 75N99024F00038Order under IDV 47PA0420D0064C107469 ELECTRICAL SUBSTATION UPGRADE PHASE 1A
- Signed
- Sep 26, 2024FY2024
- Competition
- Not available for competitionUtilities (FAR 6.302-1(b)(3))
- Obligated to date
- $122,189,393
- 75N90025C00008PHARMACEUTICALS AND RELATED SUPPLIES FOR NIH CLINICAL CENTER, PHARMACY DEPT. UNITED STATES DEPARTMENT OF DEFENSE:1133869 [25-001813]
- Signed
- Feb 6, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $93,536,123
- 75N90024C00007PHARMACEUTICALS AND RELATED SUPPLIES FOR THE NIH CLINICAL CENTER (CC), PHARMACY DEPARTMENT.
- Signed
- Nov 14, 2023FY2024
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $82,620,000
- 75N98026C00026PHARMACEUTICALS AND RELATED SUPPLIES UNITED STATES DEPARTMENT OF DEFENSE:1133869 [26-003472]
- Signed
- Apr 9, 2026FY2026
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $77,389,000
- 75D30124C19450DOSE RECONSTRUCTION
- Signed
- Aug 9, 2024FY2024
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $57,750,000
- 75A50125C00002MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE
- Signed
- Jan 31, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $53,212,199
- 75D30125C20468ATL FT COLLINS GUARDS BRIDGE
- Signed
- Sep 4, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $49,658,504
- 75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MG
- Signed
- Sep 26, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $45,499,950
- 75FCMC24F0196Order under IDV 75FCMC23D0004POLICY AND OPERATIONAL SERVICES IN SUPPORT OF THE CONSUMER SUPPORT GROUP (CSG) FOR THE CENTER FOR CONSUMER INFORMATION AND INSURANCE OVERSIGHT (CCIIO)
- Signed
- Sep 23, 2024FY2024
- Competition
- Not competedMobilization, essential r&d (FAR 6.302-3)
- Obligated to date
- $45,440,097
- 75D30126C21564EO 14398 - CDC EMERGENCY MASS NOTIFICATION SYSTEM (EMNS)
- Signed
- Sep 28, 2026FY2026
- Competition
- Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
- Obligated to date
- $37,385,495
- 75R60225C00001PRB184 C 5299 COVID-19 UNINSURED AND PROVIDER RELIEF FUND CLOSE-OUT SERVICES
- Signed
- Oct 11, 2024FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $35,520,831
- 75FCMC24F0200Order under IDV 75FCMC23D0004STRATEGIC SERVICES IN SUPPORT OF FACILITATING LEADERSHIP IN ADVANCED MEASUREMENT EXCELLENCE (FLAME)
- Signed
- Sep 16, 2024FY2024
- Competition
- Not competedMobilization, essential r&d (FAR 6.302-3)
- Obligated to date
- $35,210,195
- 75ACF124C00023CASE COORDINATION BRIDGE
- Signed
- Sep 30, 2024FY2024
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $35,175,033
- 75FCMC24F0100Order under IDV 75FCMC23D0004TITLE IS SOLUTIONS TO SUPPORT INNOVATION IN PURSUIT OF AFFORDABLE AND BETTER HEALTH CARE
- Signed
- Jun 26, 2024FY2024
- Competition
- Not competedMobilization, essential r&d (FAR 6.302-3)
- Obligated to date
- $33,645,144
- 75A50325C00020RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
- Signed
- Sep 30, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $33,392,937
- 75F40126C00029SENTINEL 2.0 BRIDGE CONTRACT
- Signed
- Mar 26, 2026FY2026
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $32,918,651
- 75FCMC25FJ092Order under IDV 75FCMC23D0004THE PURPOSE OF THIS REWARD IS TO REPLACE THE ORIGINAL ADVANCING THE MEDICAID IT AMIT AWARD 75FCMC18D0047/ 75FCMC25FJ068 DUE TO AN ADMINISTRATIVE ERROR WHICH OCCURRED AT THE TIME OF AWARD. NONE OF THE TERMS AND CONDITIONS HAVE CHANGES AND ALL ATTACHME
- Signed
- Jul 30, 2025FY2025
- Competition
- Not competedMobilization, essential r&d (FAR 6.302-3)
- Obligated to date
- $26,686,962
- 75A50424C00006OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION
- Signed
- Sep 5, 2024FY2024
- Competition
- Not competedMobilization, essential r&d (FAR 6.302-3)
- Obligated to date
- $26,510,400
- 75D30124C19403NATIONAL PROGRAM OF CANCER REGISTRIES CANCER SURVEILLANCE INFORMATICS SYSTEM
- Signed
- Jul 17, 2024FY2024
- Competition
- Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
- Obligated to date
- $26,321,728
- 75P00125C00034HHS PROCESSES IMPROVEMENT & ATO TRANSFORMATION
- Signed
- Sep 30, 2025FY2025
- Competition
- Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
- Obligated to date
- $25,242,264
- 75D30126C20921DOSE RECONSTRUCTION AND RELATED ACTIVITIES TO SUPPORT NIOSH'S RESPONSIBILITIES UNDER THE EEOICPA
- Signed
- Apr 17, 2026FY2026
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $24,823,495
- 75H70124C00052WESTERN OREGON SERVICE UNIT (WOSU) SCHOOL BASED HEALTH CENTER (SBHC) DESIGN-BUILD
- Signed
- Sep 27, 2024FY2024
- Competition
- Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
- Obligated to date
- $22,640,641